Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 90178763 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Christina M. Licursi |
Attorney Docket Number | B14622000100 |
2015-05-01 | Date of First Use |
2020-09-14 | Application Filed |
2020-09-30 | Location: NEW APPLICATION PROCESSING |
2020-09-30 | Status: Live/Pending |
2020-10-20 | Transaction Date |
Owner: | ![]() |
Address | 95 Sawyer Rd., Suite 500 Waltham MA 02453 |
Legal Entity Type | Corporation |
Legal Entity State | MA |
![]() | MULTI | 2020-09-14 |
![]() | JPEG | 2020-09-14 |
![]() | JPEG | 2020-09-14 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; providing online computer databases of genomic sequences for scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, and biochemistry; providing an online portal featuring medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online portal featuring medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes |
GS0441 | Providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-10-20 | 1 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2020-11-23 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2020-11-23 | 3 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2020-11-23 | 4 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-11-23 | 5 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-03-09 | 6 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-03-09 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-03-09 | 8 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2021-03-11 | 9 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2021-03-11 | 10 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-03-11 | 11 GNS3 O:Outgoing Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2021-03-17 | 12 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2021-03-17 | 13 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-03-17 | 14 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2021-03-17 | 15 XAEC I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2021-03-17 | 16 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2021-03-17 | 17 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-03-17 | 18 GNS3 O:Outgoing Correspondence |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2021-09-23 | 19 RCSC S: |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2022-03-23 | 20 RCSC S: |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2022-09-26 | 21 RCSC S: |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2023-03-27 | 22 RCSC S: |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-09-25 | 23 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-10-11 | 24 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2023-10-31 | 25 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-10-31 | 26 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2024-01-16 | 27 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-01-16 | 28 NRCC E:E-Mail |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-01-22 | 29 NRCC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.